Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carbapenemase-Encoding Genes and Colistin Resistance in Gram-Negative Bacteria During the COVID-19 Pandemic in Mexico: Results from the Invifar Network.
Garza-Ramos U, Silva-Sánchez J, López-Jácome LE, Hernández-Durán M, Colín-Castro CA, Sánchez-Pérez A, Rodríguez-Santiago J, Morfín-Otero R, Rodriguez-Noriega E, Velázquez-Acosta MD, Vázquez-Larios MDR, Feliciano-Guzmán JM, Rojas-Larios F, Ponce-De-Leon A, Lozano-Garcia M, Choy-Chang EV, López-Gutiérrez E, Molina-Jaimes A, Gil-Veloz M, Corte-Rojas RE, López-Ovilla I, Ramirez-Mis JL, Rodríguez-Balderas DE, Molina-Chavarria A, Padilla-Ibarra C, Quevedo-Ramos MA, Mireles-Dávalos CD, Rodríguez-Medina N, Rubio-Mendoza D, Córdova-Fletes C, Cruz-López F, Becerra-Montejano DA, Mercado-Longoria R, Martínez-Villarreal RT, Barlandas-Rendón NRE, Mena-Ramírez JP, Couoh-May CA, Alcaraz-Espejel M, Adame-Alvarez C, Hernández-Vicente L, Garza-González E. Garza-Ramos U, et al. Among authors: adame alvarez c. Microb Drug Resist. 2023 Jun;29(6):239-248. doi: 10.1089/mdr.2022.0226. Epub 2022 Dec 30. Microb Drug Resist. 2023. PMID: 36595348
The Evolution of Antimicrobial Resistance in Mexico During the Last Decade: Results from the INVIFAR Group.
Garza-González E, Franco-Cendejas R, Morfín-Otero R, Echaniz-Aviles G, Rojas-Larios F, Bocanegra-Ibarias P, Flores-Treviño S, Ponce-de-León A, Rodríguez-Noriega E, Alavez-Ramírez N, Mena-Ramirez JP, Rincón-Zuno J, Fong-Camargo MG, Morales-De-la-Peña CT, Huerta-Baltazar CR, López-Jacome LE, Carnalla-Barajas MN, Soto-Noguerón A, Sanchez-Francia D, Moncada-Barrón D, Ortíz-Brizuela E, García-Mendoza L, Newton-Sánchez OA, Choy-Chang EV, Aviles-Benitez LK, Martínez-Miranda R, Feliciano-Guzmán JM, Peña-Lopez CD, Couoh-May CA, López-Gutiérrez E, Gil-Veloz M, Armenta-Rodríguez LC, Manriquez-Reyes M, Gutierrez-Brito M, López-Ovilla I, Adame-Álvarez C, Barajas-Magallón JM, Aguirre-Burciaga E, Coronado-Ramírez AM, Rosales-García AA, Sida-Rodríguez S, Urbina-Rodríguez RE, López-Moreno LI, Juárez-Velázquez GE, Martínez-Villarreal RT, Canizales-Oviedo JL, Cetina-Umaña CM, Perez-Juárez MM, González-Moreno A, Romero-Romero D, Bello-Pazos FD, Aguilar-Orozco G, Barlandas-Rendón NRE, Maldonado-Anicacio JY, Valadez-Quiroz A, Camacho-Ortiz A. Garza-González E, et al. Among authors: adame alvarez c. Microb Drug Resist. 2020 Nov;26(11):1372-1382. doi: 10.1089/mdr.2019.0354. Epub 2020 Feb 6. Microb Drug Resist. 2020. PMID: 32027229